Ticker > Company >

Gaudium IVF & Women share price

Gaudium IVF and Women Health Ltd.

NSE: GAUDIUMIVF BSE: 544709 SECTOR: Hospital & Healthcare Services  1.08 K   0   0

81.26
-0.47 (-0.58%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 82.5

Today's Low

₹ 77.65

52 Week High

₹ 87.15

52 Week Low

₹ 71.85

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

591.47 Cr.

Enterprise Value

603.67 Cr.

No. of Shares

7.28 Cr.

P/E

31.82

P/B

2.88

Face Value

₹ 5

Div. Yield

0 %

Book Value (TTM)

₹  28.26

CASH

6.73 Cr.

DEBT

18.93 Cr.

Promoter Holding

71.29 %

EPS (TTM)

₹  2.55

Sales Growth

28.44%

ROE

51.56 %

ROCE

49.31%

Profit Growth

87.23 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year28.44%
3 Year17.34%
5 YearNA

Profit Growth

1 Year87.23%
3 Year26.88%
5 YearNA

ROE%

1 Year51.56%
3 Year57.85%

ROCE %

1 Year49.31%
3 Year57.06%

Debt/Equity

0.4168

Price to Cash Flow

70.11

Interest Cover Ratio

16.2021

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Feb 2026 71.29 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.3395432016126% for the Past 3 years.
  • Company has been maintaining healthy ROE of 57.8527666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 57.0638% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 16.2021.
  • The company has an efficient Cash Conversion Cycle of 45.4125 days.
  • The company has a high promoter holding of 71.29%.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 36.52 44.01 45.94 59
Total Expenditure 22.72 24.24 27.05 30.9
Operating Profit 13.8 19.78 18.89 28.1
Other Income 0 0.02 0.26 0.23
Interest 0.56 0.44 0.9 1.62
Depreciation 0.97 1.41 2.13 2.01
Exceptional Items 0 0 0 0
Profit Before Tax 12.27 17.95 16.13 24.7
Tax 3.17 4.69 6.2 6.11
Net Profit 9.1 13.26 9.93 18.59
Adjusted EPS (Rs.) 1.48 2.16 1.62 3.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.99 0.99 0.99 30.7
Total Reserves 8.58 21.84 25.67 14.74
Borrowings 2.25 2.02 1.93 1.73
Other N/C liabilities -0.21 0.52 2.4 2.48
Current liabilities 8.97 9.64 19.81 25.34
Total Liabilities 20.58 35.01 50.8 74.98
Assets
Net Block 3.99 15.81 18.2 17.67
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 7.38
Investments 0 1.25 1.25 6.26
Loans & Advances 0 0 2.67 4.19
Other N/C Assets 0 0 0 0.01
Current Assets 16.58 17.95 28.68 39.47
Total Assets 20.58 35.01 50.8 74.98
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0 17.95 16.41 24.88
Adjustment 0 1.71 2.65 3.27
Changes in Assets & Liabilities 0 8.98 -13.84 -15.1
Tax Paid 0 -4.63 -1.76 -4.61
Operating Cash Flow 0 24.01 3.47 8.44
Investing Cash Flow 0 -14.47 -5.37 -15.17
Financing Cash Flow 0 3.5 -1.24 1.82
Net Cash Flow 0 13.04 -3.14 -4.92

Corporate Actions

Investors Details

PARTICULARS Feb 2026%
promoters 71.29
gautam anand 0.01
manika khanna 70.73
peeyush khanna 0.30
vishad khanna 0.26
PARTICULARS Feb 2026%
investors 28.71
carnelian india multi str... 1.74
hornbill orchid india fun... 1.74
meru investment fund pcc-... 2.96
minerva emerging opportun... 1.65
neomile india opportunity... 2.20
sanshi fund-i 2.17

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Gaudium IVF & Women Stock Price Analysis and Quick Research Report. Is Gaudium IVF & Women an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Gaudium IVF & Women. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Gaudium IVF & Women has a PE ratio of 31.6677761679132 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Gaudium IVF & Women has ROA of 29.556% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Gaudium IVF & Women has a Current ratio of 1.5576.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Gaudium IVF & Women has a ROE of 51.564%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Gaudium IVF & Women has a Debt to Equity ratio of 0.4168 which means that the company has low proportion of debt in its capital.

  • Sales growth: Gaudium IVF & Women has reported revenue growth of 28.4372% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Gaudium IVF & Women for the current financial year is 47.622437357631%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Gaudium IVF & Women is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Gaudium IVF & Women is Rs 2.5537. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Gaudium IVF & Women in Ticker for free. Also, one can get the intrinsic value of Gaudium IVF & Women by using Valuation Calculators, which are available with a Finology ONE subscription. 

Gaudium IVF & Women FAQs

Q1. What is Gaudium IVF & Women share price today?
Ans: The current share price of Gaudium IVF & Women is Rs 80.87.

Q2. What is the market capitalisation of Gaudium IVF & Women?
Ans: Gaudium IVF & Women has a market capitalisation of Rs 588.627530908 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Gaudium IVF & Women?
Ans: The PE ratio of Gaudium IVF & Women is 31.6677761679132 and the P/B ratio of Gaudium IVF & Women is 2.86175328834456, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Gaudium IVF & Women share?
Ans: The 52-week high share price of Gaudium IVF & Women is Rs 87.15, and the 52-week low share price of Gaudium IVF & Women is Rs 72.02.

Q5. Does Gaudium IVF & Women pay dividends?
Ans: Currently, Gaudium IVF & Women does not pay dividends. Dividend yield of Gaudium IVF & Women is around 0%.

Q6. What are the face value and book value of Gaudium IVF & Women shares?
Ans: The face value of Gaudium IVF & Women shares is Rs 5, while the book value per share of Gaudium IVF & Women is around Rs 28.2589. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Gaudium IVF & Women?
Ans: Gaudium IVF & Women has a total debt of Rs 18.9344 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Gaudium IVF & Women?
Ans: The ROE of Gaudium IVF & Women is 51.564% and ROCE of Gaudium IVF & Women is 49.3128%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Gaudium IVF & Women a good buy for the long term?
Ans: The Gaudium IVF & Women long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Gaudium IVF & Women undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Gaudium IVF & Women appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Gaudium IVF & Women’s financials?
Ans: You can review Gaudium IVF & Women’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Gaudium IVF & Women
X